The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
Open accessAbstract
BACKGROUND: Patients with arthritis and vascular disease may receive both low-dose aspirin and other nonsteroidal antiinflammatory drugs. We therefore investigated potential interactions between aspirin and commonly prescribed arthritis therapies METHODS: We administered the following combinations of drugs for six days: aspirin (81 mg every morning) two hours before ibuprofen (400 mg every morning) and the same medications in the reverse order; aspirin two hours before acetaminophen (1000 mg every morning) and the same medications in the reverse order; aspirin two hours before the cyclooxygenase-2 inhibitor rofecoxib (25 mg every morning) and the same medications in the reverse order; enteric-coated aspirin two hours before ibuprofen (400 mg three times a day); and enteric-coated aspirin two hours before delayed-release diclofenac (75 mg twice daily) RESULTS: Serum thromboxane B(2) levels (an index of cyclooxygenase-1 activity in platelets) and platelet aggregation were maximally inhibited 24 hours after the administration of aspirin on day 6 in the subjects who took aspirin before a single daily dose of any other drug, as well as in those who took rofecoxib or acetaminophen before taking aspirin. In contrast, inhibition of serum thromboxane B(2) formation and platelet aggregation by aspirin was blocked when a single daily dose of ibuprofen was given before aspirin, as well as when multiple daily doses of ibuprofen were given. The concomitant administration of rofecoxib, acetaminophen, or diclofenac did not affect the pharmacodynamics of aspirin CONCLUSIONS: The concomitant administration of ibuprofen but not rofecoxib, acetaminophen, or diclofenac antagonizes the irreversible platelet inhibition induced by aspirin. Treatment with ibuprofen in patients with increased cardiovascular risk may limit the cardioprotective effects of aspirin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It can also antagonize the platelet inhibition induced by low dose aspirin and lessens its cardioprotective effect (46).”
From Paracetamol: New Vistas of an Old Drug (2006) · cites this paper as [46]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bombardier, C., Laine, L., Reicin, A. S., Shapiro, D., Burgos‐Vargas, R., Davis, B. R., Day, R. O., Ferraz, M. B., Hawkey, C. J., Hochberg, M. C., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011233432103 · Cited by 4,014
Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
Steering Committee of the Physicians' Health Study Research Group (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210301 · Cited by 2,267
The Coxibs, Selective Inhibitors of Cyclooxygenase-2
FitzGerald, G. A., & Patrono, C. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108093450607 · Cited by 1,572
Self-citationMcAdam, B. F., Catella-Lawson, F., Mardini, I. A., Kapoor, S. C., Lawson, J. A., & FitzGerald, G. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.272 · Cited by 1,304
Self-citationThe X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1
Picot, D., Loll, P. J., & Garavito, R. M. (1994) · Nature · doi:10.1038/367243a0 · Cited by 1,270
Patrono, C., Coller, B. S., Dalen, J. E., Gerald, G. A. F., Fuster, V., Gent, M., Hirsh, J., & Roth, G. J. (2001) · CHEST Journal · doi:10.1378/chest.119.1_suppl.39s · Cited by 961
Patrignani, P., Filabozzi, P., & Patrono, C. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110576 · Cited by 931
Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2
Luong, C., Miller, A. B., Barnett, J. W., Chow, J., Ramesha, C. S., & Browner, M. F. (1996) · Nature Structural Biology · doi:10.1038/nsb1196-927 · Cited by 620
Catella-Lawson, F., McAdam, B. F., Morrison, B. W., Kapoor, S. C., Kujubu, D. A., Antes, L. M., Lasseter, K. C., Quan, H., Gertz, B. J., & FitzGerald, G. A. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38195-9 · Cited by 596
Self-citation
Flagged first, then by citations
Research works printed but not linked: 7
- Singh G, 1999, J Rheumatol, 26, 18
- Patrignani P, 1999, J Physiol Pharmacol, 50, 661
- Pathmakanthan S, 1998, Ir Med J, 91, 58
- Patrignani P, 1994, J Pharmacol Exp Ther, 271, 1705
- Sciulli MG, Patrignani P, Seta F, et al. Effects of acetaminophen on constitutive and inducible prostanoid biosynthesis in human blood cells in vitro. In: Proceedings of the 11th International Conference on Advances in Prostaglandin and Leukotriene Research: Basic Science and New Clinical Applications, Florence, Italy, June 4–8, 2000:38. abstract.
- Reilly IAG, 1987, Blood, 69, 180, 10.1182/blood.V69.1.180.180 · DOI
- Catella-Lawson F, 1999, J Pharmacol Exp Ther, 289, 735
Cited by
Sorted by citations
Items 601–700 of 1,000
Hawkey, C. J., Hawkey, G. M., Everitt, S., Skelly, M. M., Stack, W. A., & Gray, D. P. (2006) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02644.x · Cited by 21
The Clinical Relevance of Response Variability to Antiplatelet Therapy
Cattaneo, M. (2011) · Hematology · doi:10.1182/asheducation-2011.1.70 · Cited by 21
Bista, D., Palaian, S., Shankar, P. R., Prabhu, M. M., Paudel, R., & Mishra, P. (2007) · PubMed · Cited by 21
Safety Considerations in Prescription of NSAIDs for Musculoskeletal Pain: A Narrative Review
Hatt, K., Vijapura, A., Maitin, I. B., & Cruz, E. S. (2018) · PM&R · doi:10.1016/j.pmrj.2018.06.011 · Cited by 21
Jajić, Z., Malaise, M., Nékám, K., Koó, É., Dankó, K., Kovács, M., & Scarpignato, C. (2005) · PubMed · Cited by 21
Blaicher, A. M., Landsteiner, H. T., Al-Falaki, O., Zwerina, J., Volf, I., Gruber, D., ZIMPFER, M., & Hoerauf, K. H. (2004) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000105866.99259.94 · Cited by 21
Resistance to antiplatelet therapy
Guthikonda, S., Lev, E. I., & Kleiman, N. S. (2005) · Current Cardiology Reports · doi:10.1007/s11886-005-0044-0 · Cited by 21
Hanjis, C., Frishman, W. H., & Lerner, R. G. (2005) · Cardiology in Review · doi:10.1097/01.crd.0000148175.60718.69 · Cited by 21
NSAIDs and cardiovascular disease
Patrignani, P., Capone, M. L., & Tacconelli, S. (2007) · Heart · doi:10.1136/hrt.2007.136002 · Cited by 21
Room for improvement: unmet needs in postoperative pain management
Pogatzki-Zahn, E. M., Schnabel, A., & Zahn, P. K. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.30 · Cited by 20
Temperilli, F., Franco, M. D., Massimi, I., Guarino, M. L., Guzzo, M. P., Valesini, G., Frati, L., & Pulcinelli, F. M. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.06.016 · Cited by 20
Wulff, I., Könner, F., Kölzsch, M., Budnick, A., Dräger, D., & Kreutz, R. H. (2012) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-012-0332-4 · Cited by 20
Gremmel, T., Perkmann, T., Seidinger, D., Koppensteiner, R., Panzer, S., Kopp, C. W., & Steiner, S. (2013) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.17665 · Cited by 20
Platelet Turnover in Atherothrombotic Disease
Lordkipanidzé, M. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212803251952 · Cited by 20
Valerio, L., Sheriff, J., Tran, P. L., Brengle, W., Redaelli, A. C. L., Fiore, G. B., Pappalardo, F., Bluestein, D., & Slepian, M. J. (2017) · Thrombosis Research · doi:10.1016/j.thromres.2017.12.001 · Cited by 20
Moreira, D. D. S., Figueiró, P. W., Siebert, C., Prezzi, C. A., Rohden, F., Guma, F. T. C. R., Manfredini, V., & Wyse, Â. T. D. S. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9847-1 · Cited by 20
Dannenberg, L., Petzold, T., Achilles, A., Naguib, D., Zako, S., Helten, C., M’Pembele, R., Mourikis, P., Podsvyadek, Y., Grandoch, M., et al. (2018) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-018-2560-z · Cited by 20
Oral administration of hydrolysates of cartilage extract in the prevention of osteoarthritis
Ma, C., Yu, M., Huang, Z., Wang, J., Zhao, X., Kang, C., Xu, H., Wang, Y., & Hou, H. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104376 · Cited by 20
Pharmacology in Rehabilitation: Nonsteroidal Anti-inflammatory Agents
Biederman, R. E. (2005) · Journal of Orthopaedic and Sports Physical Therapy · doi:10.2519/jospt.2005.35.6.356 · Cited by 20
Confirmation of Reported Aspirin Use in Community Studies
Zantek, N. D., Luepker, R. V., Duval, S., Miller, K. H., Oldenburg, N. C., & Hirsch, A. T. (2013) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029613486537 · Cited by 20
The case for an adverse interaction between aspirin and non-steroidal anti-inflammatory drugs
Curtis, J. P., & Krumholz, H. M. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.01.001 · Cited by 20
Aspirin or P2Y12 inhibitor monotherapy in atherosclerotic cardiovascular disease?
Galli, M., ten Berg, J. M., Valgimigli, M., Capodanno, D., Gragnano, F., Kimura, T., Bhatt, D. L., Gibson, C. M., Mehran, R., & Angiolillo, D. J. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf718 · Cited by 24
Anti-Inflammatory Drugs in Patients with Ischemic Heart Disease
Lázaro, A. M. P., Blanco‐Colio, L. M., Peláez, J. A. F., & Tuñón, J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10132835 · Cited by 19
Papp, J., Sándor, B., Vámos, Z., Botor, D., Tóth, A., Rábai, M., Kenyeres, P., Cséplő, P., Juricskay, I., Mezősi, E., et al. (2014) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-2012-1636 · Cited by 19
Gorelick, P. B., & Farooq, M. U. (2013) · Stroke Research and Treatment · doi:10.1155/2013/727842 · Cited by 19
Drug–Drug Interactions in Cardiovascular Catheterizations and Interventions
Dunn, S. P., Holmes, D. R., & Moliterno, D. J. (2012) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2012.10.005 · Cited by 19
Cardiovascular risk associated with nonsteroidal anti-inflammatory drugs
Hermann, M. (2009) · Current Rheumatology Reports · doi:10.1007/s11926-009-0005-5 · Cited by 19
Impairment of aspirin antiplatelet effects by non-opioid analgesic medication
Polzin, A. (2015) · World Journal of Cardiology · doi:10.4330/wjc.v7.i7.383 · Cited by 19
Krauss, E. S., Cronin, M., Dengler, N., & Segal, A. (2020) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029620920373 · Cited by 19
Krauss, E. S., Cronin, M., Dengler, N., Simonson, B. G., Enker, P., & Segal, A. (2020) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029620961450 · Cited by 19
Using NSAIDs in cardiovascular disease
(2010) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2010.01.0007 · Cited by 19
Cardiovascular Risks of Cyclooxygenase Inhibition
Stacy, Z. A., Dobesh, P. P., & Trujillo, T. C. (2006) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.26.7.919 · Cited by 19
The platelet P2Y receptors as targets for new antithrombotic drugs
Cattaneo, M. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00286.x · Cited by 19
Platelets: Still a Therapeutical Target for Haemostatic Disorders
Geraldo, R. B., Sathler, P. C., Lourenço, A. L., Saito, M. S., Cabral, L., Rampelotto, P. H., & Castro, H. C. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151017901 · Cited by 21
Newburger, J. W., & Fulton, D. R. (2007) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-007-0008-3 · Cited by 19
Giving aspirin and ibuprofen after myocardial infarction
Kimmel, S. E., & Strom, B. L. (2003) · BMJ · doi:10.1136/bmj.327.7427.1298 · Cited by 19
NSAIDS and Aspirin: Recent Advances and Implications for Clinical Management
Schrör, K., & Voelker, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-33889-7_7 · Cited by 18
Resistance to aspirin and clopidogrel therapy
Musallam, K. M., Charafeddine, K. M., Bitar, A., Khoury, M., Assaad, S., Beresian, J., Alam, S., & Taher, A. T. (2010) · International Journal of Laboratory Hematology · doi:10.1111/j.1751-553x.2010.01268.x · Cited by 18
Linnemann, B., Prochnow, S., Mani, H., Schwonberg, J., & Lindhoff‐Last, E. (2009) · Annals of Hematology · doi:10.1007/s00277-009-0708-8 · Cited by 18
Pain Management in Critically Ill Patients: A Review of Multimodal Treatment Options
Kohler, M., Chiu, F., Gelber, K. M., Webb, C. A.-J., & Weyker, P. D. (2016) · Pain Management · doi:10.2217/pmt-2016-0002 · Cited by 18
Castelli, G., Petrone, A. B., Xiang, J., Shrader, C. D., & King, D. E. (2017) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-016-0212-1 · Cited by 18
Bastaki, S. M. A., Padol, I. T., Amir, N., & Hunt, R. H. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-3110-1 · Cited by 19
Cipriani, S., Mencarelli, A., Bruno, A. M., Renga, B., Distrutti, E., Santucci, L., Baldelli, F., & Fiorucci, S. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02128.x · Cited by 18
Antiplatelet Agents in Acute Coronary Syndromes
Sakhuja, R., Yeh, R. W., & Bhatt, D. L. (2010) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2009.11.002 · Cited by 18
Gurbel, P. A., & Tantry, U. S. (2012) · Springer eBooks · doi:10.1007/978-1-4471-4297-3_2 · Cited by 18
Layton, D., Wilton, L., & Shakir, S. (2004) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-004-0788-2 · Cited by 18
Mechanisms of variability in antiplatelet agents response
Cattaneo, M. (2012) · Thrombosis Research · doi:10.1016/j.thromres.2012.08.266 · Cited by 18
Pain Control:COX-2–Selective NSAIDs
Hutchison, R. (2004) · AJN American Journal of Nursing · doi:10.1097/00000446-200403000-00021 · Cited by 18
Oral antiplatelet agents in cardiovascular disease
Pultar, J., Wadowski, P. P., Panzer, S., & Gremmel, T. (2018) · VASA · doi:10.1024/0301-1526/a000753 · Cited by 18
Moskowitz, R. W., Abramson, S. B., Berenbaum, F., Simon, L. S., & Hochberg, M. (2007) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2007.06.012 · Cited by 18
Acquired Disorders of Platelet Function
Rao, A. K. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-387837-3.00051-1 · Cited by 19
Crossreacting Drugs and Chemicals
Woessner, K. M. (2003) · Clinical Reviews in Allergy & Immunology · doi:10.1385/criai:24:2:149 · Cited by 18
Species Differences in Platelet Protease-Activated Receptors
Renna, S. A., McKenzie, S. E., & Michael, J. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098298 · Cited by 17
Non-steroidal anti-inflammatory drugs
Patrono, C. (2011) · Elsevier eBooks · doi:10.1016/b978-0-323-06551-1.00050-6 · Cited by 17
Karnabatidis, D., Spiliοpoulos, S., Pastromas, G., Kitrou, P. M., Christeas, N. C., Katsanos, K. H., & Siablis, D. (2013) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-013-0710-3 · Cited by 17
Angiolillo, D. J., Hwang, C., Datto, C. J., Desai, B., & Sostek, M. B. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.10.009 · Cited by 17
Dar-Odeh, N. S., Elsayed, S., Babkair, H. A., Abu‐Hammad, S., Althagafi, N. M., Bahabri, R., Eldeen, Y. S., Al-Johani, W. A., & Abu-Hammad, O. A. (2020) · Journal of Dental Sciences · doi:10.1016/j.jds.2020.11.007 · Cited by 17
Li, Y., Cai, B., Zhang, Z., Qu, G., Chen, L., Chen, G., Liang, T., Yang, C., Fan, L., & Zhang, Z. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.05.024 · Cited by 17
Risk Reduction Strategies in Ischaemic Stroke
Alberts, M. J., & Atkinson, R. (2004) · Clinical Drug Investigation · doi:10.2165/00044011-200424050-00001 · Cited by 17
Temperilli, F., Rina, A., Massimi, I., Montemari, A. L., Guarino, M. L., Zicari, A., & Pulcinelli, F. M. (2015) · Platelets · doi:10.3109/09537104.2014.1003291 · Cited by 17
Battle, C. E., Hutchings, H. A., Bouamra, O., & Evans, P. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091284 · Cited by 17
Nonsteroidal Anti-Inflammatory Drugs and Their Effects in the Elderly
Park, K. E., Qin, Y., & Bavry, A. A. (2012) · Aging Health · doi:10.2217/ahe.12.6 · Cited by 17
Utility of published guidelines on the use of nonsteroidal anti-inflammatory drugs in the elderly
Juby, A. G., & Davis, P. J. (2008) · Clinical Rheumatology · doi:10.1007/s10067-008-0952-7 · Cited by 17
Acetylsalicylic acid resistance risk factors in patients with myocardial infarction
Stolarek, W., Kasprzak, M., Obońska, K., Ostrowska, M., Wiciński, M., Kubica, A., Kubica, J., & Grześk, G. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.02.006 · Cited by 17
The dose of aspirin for the prevention of cardiovascular and cerebrovascular events
Fisher, M., & Knappertz, V. A. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x112624 · Cited by 17
Busch, L., Stern, M. E., Dannenberg, L., Mourikis, P., Gröne, M., Özaslan, G., Heinen, Y., Heiß, C., Sansone, R., Polzin, A., et al. (2020) · Platelets · doi:10.1080/09537104.2020.1742314 · Cited by 17
Sundel, R. P., & Petty, R. E. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-6581-4.10033-0 · Cited by 17
Impact of Nonsteroidal Antiinflammatory Drugs on the Cardioprotective Effects of Aspirin
Corman, S. L., Fedutes, B. A., & Ansani, N. T. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e514 · Cited by 17
Plaquetas: ainda um alvo terapêutico
Castro, H. C., Ferreira, B. L. A., Nagashima, T., Schueler, A., Rueff, C., Camisasca, D. R., Moreira, G., Scovino, G., Borges, L., Leal, M. D. C., et al. (2006) · Jornal Brasileiro de Patologia e Medicina Laboratorial · doi:10.1590/s1676-24442006000500004 · Cited by 17
Burke, J., Kraft, W. K., Greenberg, H. E., Gleave, M., Pitari, G. M., VanBuren, S., Wagner, J. A., & Waldman, S. A. (2003) · The Journal of Clinical Pharmacology · doi:10.1177/0091270003257216 · Cited by 17
der DGRh, K. P., Bolten, W. W., Krüger, K., Reiter-Niesert, S., & Stichtenoth, D. O. (2016) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-015-0018-6 · Cited by 16
Synthesis, Stability, and Biological Studies of Fluorinated Analogues of Thromboxane A2
Jing, C., Mallah, S., Kriemen, E., Bennett, S. H., Fasano, V., Lennox, A. J. J., Hers, I., & Aggarwal, V. K. (2020) · ACS Central Science · doi:10.1021/acscentsci.0c00310 · Cited by 16
Guo, Z., Liu, Y., & Xing, X. (2010) · Process Biochemistry · doi:10.1016/j.procbio.2010.10.017 · Cited by 16
Aspirin Resistance in Hypertensive Patients
Özben, B., Tanrikulu, A. M., Özben, T., & Caymaz, O. (2010) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2010.00307.x · Cited by 16
Diabetes mellitus: a prothrombotic state. Implications for outcomes after coronary revascularization
Cola, C. (2009) · Vascular Health and Risk Management · doi:10.2147/vhrm.s4248 · Cited by 16
The Editor’s Roundtable: Cyclooxygenase-2 Inhibitors and Cardiovascular Risk
Bresalier, R. S., Friedewald, V. E., Rakel, R. E., Roberts, W. C., & Williams, G. W. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.09.069 · Cited by 16
Fallahi, P., Katz, R. J., Toma, I., Li, R., Reiner, J. S., VanHouten, K., Carpio, L., Marshall, L. R., Lian, Y., Bupp, S., et al. (2013) · Gene · doi:10.1016/j.gene.2013.02.032 · Cited by 16
Pillai, L., Levy, R. M., Yimam, M., Zhao, Y., Jia, Q., & Burnett, B. P. (2010) · Advances in Therapy · doi:10.1007/s12325-010-0040-7 · Cited by 16
Aspirin and Antiplatelet Agent Resistance
Greer, D. M. (2010) · CNS Drugs · doi:10.2165/11539160-000000000-00000 · Cited by 16
Mosaad, S. M., Zaitone, S. A., Ibrahim, A., El-Baz, A. A., Abo–Elmatty, D. M., & Moustafa, Y. M. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.05.012 · Cited by 16
Hochberg, M. C. (2003) · Arthritis Research · doi:10.1186/ar617 · Cited by 16
Kroll, M. H., & Feng, S. (2005) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.3.5.941 · Cited by 16
NSAIDs without a prescription: over-the-counter access, under-counted risks
Scheiman, J. M., & Fendrick, A. M. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)04322-8 · Cited by 16
Effect of ibuprofen on cardioprotective effect of aspirin
Weiss, H. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13191-1 · Cited by 16
Antiplatelet drug therapy: role of pharmacodynamic and genetic testing.
Tello-Montoliu, A., Ueno, M., & Angiolillo, D. (2011) · Future Cardiology · doi:10.2217/fca.11.14 · Cited by 14
Dei, M., Rizzo, J., Scavone, M., Femia, E. A., Podda, G. M., Bossi, E., Monica, B., Caberlon, S., Cattaneo, M., & Paroni, R. C. (2021) · Scientific Reports · doi:10.1038/s41598-021-89671-w · Cited by 15
Grimaldi‐Bensouda, L., Rossignol, M., Danchin, N., Steg, P. G., Bessede, G., Ovize, M., Cottin, Y., Autret‐Leca, E., Bénichou, J., Abenhaim, L., et al. (2011) · Heart · doi:10.1136/hrt.2011.222448 · Cited by 15
Tzoran, I., Brenner, B., Sakharov, G., Trujillo‐Santos, J., Lorenzo, A., Madridano, O., López‐Sáez, J. B., & Monréal, M. (2014) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2014.09.010 · Cited by 15
Stepensky, D., & Rimon, G. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.971010 · Cited by 15
Chunduri, N. S., Kollu, T., Goteki, V. R., Mallela, K. K., & Madasu, K. (2013) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.110910 · Cited by 15
Development of Porous Nanomaterials for Applications in Drug Delivery and Imaging
Datt, A., Ndiege, N., & Larsen, S. C. (2012) · ACS symposium series · doi:10.1021/bk-2012-1119.ch011 · Cited by 15
Bisphosphonates as anti-inflammatory agents in ankylosing spondylitis and spondylarthropathies
Toussirot, É., & Wendling, D. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.1.35 · Cited by 15
Sohn, S., & Kwon, K. (2007) · Pediatric Cardiology · doi:10.1007/s00246-007-9123-x · Cited by 15
Effets rénaux et cardiovasculaires des anti-inflammatoires non stéroïdiens et des coxibs
Deray, G. (2004) · La Presse Médicale · doi:10.1016/s0755-4982(04)98637-x · Cited by 15
Chan, F. K. L. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01545.x · Cited by 15
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
McQuillan, A., & Eikelboom, J. W. (2002) · New England Journal of Medicine · doi:10.1056/nejm200205163462018 · Cited by 15
Cardiovascular Risk in Rheumatoid Arthritis: Literature Review
Hannawi, S., Hannawi, H., & Salmi, I. A. (2021) · Oman Medical Journal · doi:10.5001/omj.2021.25 · Cited by 17
Wu, J., Wang, J., Jiang, S., Xu, J., Di, Q., Zhou, C., Min, X., Pang, S., Wang, H., Xu, D., et al. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.11.078 · Cited by 14
Overcoming “aspirin resistance” in MPN
Tefferi, A. (2012) · Blood · doi:10.1182/blood-2012-02-406645 · Cited by 14
Eikelboom, J. W., Hirsh, J., Spencer, F. A., Baglin, T. P., & Weitz, J. I. (2014) · Cited by 14
Metadata
- Authors
- Catella-Lawson, F., Reilly, M. P., Kapoor, S. C., Cucchiara, A. J., DeMarco, S., Tournier, B., Vyas, S. N., & FitzGerald, G. A.
- Affiliations
- University of Pennsylvania (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2001-12-20
- Volume
- 345
- Issue
- 25
- Pages
- 1809-1817
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2011327495
- Cited by
- 1,394
- References
- 44
- Citations by year
- 2026: 19 · 2025: 15 · 2024: 18 · 2023: 18 · 2022: 33 · 2021: 43 · 2020: 33 · 2019: 40 · 2018: 40 · 2017: 46 · 2016: 41 · 2015: 56 · 2014: 46 · 2013: 69 · 2012: 79
- FWCI
- 50.64
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL 5400, HL62250, P01HL062250)
- National Center for Research Resources (M01-RR-00040, M01RR000040)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Keywords
- aspirin, ibuprofen, cyclooxygenase inhibitors, rofecoxib, diclofenac, paracetamol, drug interactions, platelet aggregation, thromboxane B2, antiplatelet activity, nonsteroidal anti-inflammatory drugs, arthritis treatment, cardiovascular risk, cardioprotection
- MeSH terms
- Acetaminophen, Adult, Anti-Inflammatory Agents, Non-Steroidal, Aspirin, Diclofenac, Drug Interactions, Drug Therapy, Combination, Humans, Ibuprofen, Isoenzymes, Lactones, Membrane Proteins, Middle Aged, Platelet Aggregation, Platelet Aggregation Inhibitors, Prostaglandin-Endoperoxide Synthases, Sulfones, Thromboxane B2, Dinoprostone, Cyclooxygenase Inhibitors, Cross-Over Studies, Analgesics, Non-Narcotic, Cyclooxygenase 1, Cyclooxygenase 2, Cyclooxygenase 2 Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
